Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.
Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.
Reuters NewMedia - Wednesday September 8, 1999
The U.S. Food and Drug Administration has approved the drugs, Zerit and Videx, for use with each other and another type of HIV drug.
Zerit and Videx, which are in a leading class of AIDS drugs known as reverse transcriptase inhibitors, have been cleared for use on their own since the early 1990s.
The two drugs can now be used with two other classes of AIDS drugs -- a protease inhibitor or a non-nucleoside analogue efavirenz.
The company said Thursday's approval reflects the prevailing approach to HIV therapy, which calls for combinations of drugs to fight the virus. Zerit posted sales of about $151 million in the second quarter, while Videx had sales of about $55 million during that period.
990908
RE990902
Copyright © 1999 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .